Learn how when the coronavirus pandemic hit, researchers at Benaroya Research Institute at Virginia Mason (BRI) quickly collaborated to apply their state-of-the-art technology and world-class immune system expertise to COVID-19. While pursuing COVID-19 answers, they’ve sustained focus on critical ongoing research into autoimmunity, allergy and asthma. This video was originally presented at the virtual 2020 Illuminations Luncheon to benefit BRI.
Featuring: Principal Investigator Cate Speake, PhD; Principal Investigator Adam Lacy-Hulbert, PhD; Associate Director of Academic Affairs Jessica Hamerman, PhD; Clinical Trial Participant Lois Busby; Clinical Research Participant Katie Busby.
BRI is a world-renowned, non-profit medical research institute committed to advancing the science that will predict, prevent, reverse and cure diseases of the immune system. To learn more, visit
